Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-05-14 @ 4:32 AM
Study NCT ID:
NCT01049620
Status:
COMPLETED
Last Update Posted:
2020-01-07
First Post:
2010-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX
Sponsor:
Asan Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AMC0905
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None